| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00003226-200007000-00018 |
| P698 | PubMed publication ID | 10928765 |
| P2093 | author name string | K Turner | |
| S C Pflugfelder | |||
| M Stern | |||
| Z Ji | |||
| W J Feuer | |||
| B L Reis | |||
| P433 | issue | 4 | |
| P921 | main subject | cyclosporine | Q367700 |
| eye disease | Q3041498 | ||
| P1104 | number of pages | 5 | |
| P304 | page(s) | 492-496 | |
| P577 | publication date | 2000-07-01 | |
| P1433 | published in | Cornea | Q15760110 |
| P1476 | title | Interleukin-6 levels in the conjunctival epithelium of patients with dry eye disease treated with cyclosporine ophthalmic emulsion | |
| P478 | volume | 19 |
| Q89536714 | An Updated Systematic Review With Meta-Analysis Of Randomized Trials On Topical Cyclosporin A For Dry-Eye Disease |
| Q79317939 | Anti-inflammatory therapy of dry eye |
| Q36625074 | Autoimmunity at the ocular surface: pathogenesis and regulation |
| Q37782084 | Clinical Review: Topical Ophthalmic Use of Cyclosporin A |
| Q38733230 | Clinical impact of inflammation in dry eye disease: proceedings of the ODISSEY group meeting |
| Q36300034 | Conjunctival Goblet Cell Function: Effect of Contact Lens Wear and Cytokines |
| Q36269034 | Corneal confocal scanning laser microscopy in patients with dry eye disease treated with topical cyclosporine |
| Q37269968 | Corneal epithelial proliferation and thickness in a mouse model of dry eye. |
| Q37644776 | Current practice pattern for dry eye patients in South Korea: a multicenter study. |
| Q35570541 | Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence |
| Q34647761 | Dry eye as a mucosal autoimmune disease |
| Q36799601 | Dry eye disease and microbial keratitis: is there a connection? |
| Q36916372 | Dry eye disease: an immune-mediated ocular surface disorder |
| Q39384374 | Dry eye. An update on epidemiology, diagnosis, therapy and new concepts |
| Q35790953 | Dry eye: diagnosis and current treatment strategies |
| Q34972968 | Dynamic ocular surface and lacrimal gland changes induced in experimental murine dry eye. |
| Q37126861 | Effect of topical 0.05% cyclosporine A on corneal endothelium in patients with dry eye disease. |
| Q36692399 | Effects of L-carnitine, erythritol and betaine on pro-inflammatory markers in primary human corneal epithelial cells exposed to hyperosmotic stress |
| Q34076208 | High-frequency topical cyclosporine 0.05% in the treatment of severe dry eye refractory to twice-daily regimen |
| Q37078848 | Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model. |
| Q37471561 | Long-term outcome after topical ciclosporin in severe dry eye disease with a 10-year follow-up |
| Q80347919 | Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007) |
| Q34028408 | Managing Sjögren's Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy. |
| Q34730735 | Ocular allergy guidelines: a practical treatment algorithm |
| Q35907009 | Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease |
| Q50991094 | Osmoprotective effects of supplemental epidermal growth factor in an ex vivo multilayered human conjunctival model under hyperosmotic stress. |
| Q37079081 | Pharmacological management of dry eye in the elderly patient |
| Q39030112 | Presence or absence of ocular surface inflammation directs clinical and therapeutic management of dry eye. |
| Q36676823 | Production and activity of matrix metalloproteinase-9 on the ocular surface increase in dysfunctional tear syndrome |
| Q61811294 | Review of Biomarkers in Ocular Matrices: Challenges and Opportunities |
| Q36718011 | Science and strategy for preventing and managing corneal ulceration. |
| Q37070035 | Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye |
| Q37374838 | T helper cytokines in dry eye disease |
| Q38750436 | The Blockade of IL6 Counterparts the Osmolar Stress-Induced Apoptosis in Human Conjunctival Epithelial Cells. |
| Q28083825 | The pathophysiology, diagnosis, and treatment of dry eye disease |
| Q38270449 | The role and treatment of inflammation in dry eye disease |
| Q37257746 | The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca. |
| Q34391944 | The treatment of dry eye. |
| Q24670344 | Topical ciclosporin in the treatment of ocular surface disorders |
| Q84735553 | Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients |
| Q90093016 | Topical cyclosporine A therapy for dry eye syndrome |
| Q36009560 | Topical fluorometholone treatment for ocular dryness in patients with Sjögren syndrome: a randomized clinical trial in China |
| Q35691929 | Treatment of ocular rosacea: comparative study of topical cyclosporine and oral doxycycline |
| Q88884763 | [Diagnosis and treatment of the watering eye] |
| Q52552723 | [Dry eye disease as a complex dysregulation of the functional anatomy of the ocular surface. New concepts for understanding dry eye disease]. |
| Q83395307 | [The "wet" dry eye] |
Search more.